Glyvia
Commercial- Indications
- Metabolic health
Company intelligence / Profile preview
Biologic Pharmamedical has launched several patented nutraceutical ingredients with peer-reviewed evidence supporting their efficacy in metabolic health, inflammation reduction, and healthy aging. Their lead products are incorporated into commercial functional beverages and supplements. The company collaborates with academic institutions on research into the mechanisms of metabolic syndrome, focusing on insulin signaling and incretin hormones such as GLP‑1. No clinical trial data or regulatory drug approvals are reported; the company operates primarily in the dietary supplement/nutraceutical space.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biologic Pharmamedical.